P207-9030 Screening compound: (3S,4S)-1-(tert-butoxycarbonyl)-4-{1-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-piperidyl}tetrahydro-1H-pyrrole-3-carboxylic acid

P207-9030 Screening compound: (3S,4S)-1-(tert-butoxycarbonyl)-4-{1-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-piperidyl}tetrahydro-1H-pyrrole-3-carboxylic acid
P207-9030 Screening compound: (3S,4S)-1-(tert-butoxycarbonyl)-4-{1-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-piperidyl}tetrahydro-1H-pyrrole-3-carboxylic acid alternative view

Chemical Structure Depiction of ChemDiv screening compound P207-9030
(3S,4S)-1-(tert-butoxycarbonyl)-4-{1-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-piperidyl}tetrahydro-1H-pyrrole-3-carboxylic acid

Available from 1 mg

Formats:

  • Glass Vials (4ml Glass Vials VWR #97047-678)
  • 96-tube racks (Matrix #4247 96-well 1.4ml sealed with capmats, empty cols 1 & 12, 100uL of 10mM)

Shiptime: 1 week worldwide delivery in most cases

Compound Identifiers

ChemDiv Compound ID

P207-9030

Molecular Formula

C30H36N2O6 (C30 H36 N2 O6)

Compound Name

(3S,4S)-1-(tert-butoxycarbonyl)-4-{1-[(9H-fluoren-9-ylmethoxy)carbonyl]-4-piperidyl}tetrahydro-1H-pyrrole-3-carboxylic acid

IUPAC name

(3S4S)-1-[(tert-butoxy)carbonyl]-4-(1-{[(9H-fluoren-9-yl)methoxy]carbonyl}piperidin-4-yl)pyrrolidine-3-carboxylic acid

SMILES

CC(C)(C)OC(N(C[C@@H]1C(CC2)CCN2C(OCC2c(cccc3)c3-c3c2cccc3)=O)C[C@@H]1C(O)=O)=O

InChI

InChI=1S/C30H36N2O6/c1-30(2,3)38-29(36)32-16-24(25(17-32)27(33)34)19-12-14-31(15-13-19)28(35)37-18-26-22-10-6-4-8-20(22)21-9-5-7-11-23(21)26/h4-11,19,24-26H,12-18H2,1-3H3,(H,33,34)/t24-,25+/m1/s1

InChI Key

VPBNTZJOFKLQIQ-RPBOFIJWSA-N

MDL Number (MFCD)

Chemical and Physical Properties

Saltdata

n/a

Molecular Weight

520.63

Hydrogen Bond Acceptors Count

9.00

Hydrogen Bond Donors Count

1.00

Rotatable Bond Count

9.00

Number of Nitrogen and Oxygen Atoms

8

Partition Coefficient, logP

5.322

Distribution Coefficient, logD

2.932

Water Solubility, LogSw

-5.21

Polar Surface Area

73.781

Acid Dissociation Constant (pKa)

5.01

Base Dissociation Constant (pKb)

0.30

Number of Chiral Centers

2.00

Percent sp3 carbon bonding

50.00

P207-9030 in Drug Discovery

Included in Screening Libraries

PPI Helix Turn 3D-Mimetics Library (71298 compounds)

Protein-Protein Interaction Library (218420 compounds)

Protein Tyrosine Phosphatase Non-receptor Type (PTPN) Targeted Library (32556 compounds)

Included in 1.7M Stock Database

Mechanism of action:
  • PPI modulators
  • PPI modulators
Structure:
  • Mimetics
Therapeutical areas:
  • Cancer
  • Nervous system
  • Male
  • Female
  • Hemic and lymphatic
  • Skin
  • Endocrine
Targets:
  • Phosphatases

References: we are preparing a list of scientific research reports with P207-9030 chemical compound. It will be published here after verification.

Frequently Asked Questions

How to purchase chemical compound P207-9030?
Check Price and Availability of P207-9030, then you can add required amount to the Shopping Cart. In the Shopping Cart you can again refine your selection. Once you are sure that it’s exactly what you want you can move forward with the Checkout (to pay online by credit card, or via PayPal), or Request a Quote.
What is the minimum amount of P207-9030 you sell to drug discovery company or institution?
Available from 1 mg in Glass Vials or 96-tube racks.
Delivery options for P207-9030
ChemDiv sends parcels with Express services (UPS, WC).
  • 1–2 days for small orders
  • 2–4 weeks for large selections
Delivery formats for P207-9030
  • 0.5–50 mg of dry powder sample in single glass vials, custom vials
  • DMSO solutions frozen 10μl–250μl@10mM (96 and 384 format)

Custom synthesis of P207-9030 available by request